Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NASDAQ:OPK)

7.85
Delayed Data
As of Mar 24
 +0.20 / +2.61%
Today’s Change
7.13
Today|||52-Week Range
12.15
-15.59%
Year-to-Date
Better Buy: Myriad Genetics, Inc. vs. Opko Health, Inc.
Mar 11 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close7.65
Today’s open7.70
Day’s range7.68 - 7.93
Volume2,826,536
Average volume (3 months)4,937,837
Market cap$4.4B
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+16.67%
Earnings growth (this year)-90.00%
Earnings growth (next 5 years)+40.10%
Revenue growth (last year)+148.44%
P/E ratioNM
Price/Sales4.19
Price/Book2.09

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc-0.09-0.21%
ALNYAlnylam Pharmaceutic...-0.70-1.33%
AGNPRAAllergan plc+4.73+0.57%
ACADACADIA Pharmaceutica...+0.38+1.10%
Data as of 4:02pm ET, 03/24/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$1.2B
Annual profit (last year)-$25.1M
Net profit margin-2.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
CFO, Treasurer, &
Chief Accounting Officer
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts


Search for Jobs